Pregnancy and Childbirth
Conditions
Interventions
Paracetamol hyoscine butyl bromide
Sponsors
Eze Jeremiah
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. The patient will be booked and will be attending antenatal care at UNTH 2. The pregnancy has to be between the gestational age of 37 week to 42 weeks and vagina delivery is anticipated 3. The patient has to be admitted in labour with cervical dilatation of 4–6 cm 4. Patient who has given written consent.
Exclusion criteria
Exclusion criteria: 1. Patient who is not booked and who is not attending antenatal care at UNTH 2. Patient that is allergic to pentazocine, paracetamol or hyoscine butylbromide 3. Patient who has contraindication to vagina delivery. 4. Pregnancy complicated by fetal distress at recruitment 5. Maternal conditions such as cardiopulmonary depression 6. History of recent/chronic liver disease. 7. History of renal disease 8. Those with prior analgesic administration will be excluded from the study. 9. Patients with history of adverse reaction to the medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.The mean pain score between women who will have intramuscular paracetamol with intramuscular hyoscine butylbromide versus women who will have intramuscular pentazocine as labour analgesia. 2.Safety between women who will have intramuscular paracetamol with intramuscular hyoscine butylbromide versus women who will receive intramuscular pentazocine as labour analgesia | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Maternal satisfaction with pain relief between the two groups 2. Duration of labour among the participants 3. Incidence of maternal/neonatal complications among the participants. 4. Delivery routes among the participants. | — |
Countries
Nigeria
Contacts
Public ContactProf. Ajah Leonard
Consultant
Outcome results
None listed